Supply of Tocilizumab (80mg/4ml, 200mg/10ml, 400mg/20ml i.v.; 162mg/0.9ml s.c.) for Hospital Pharmacy
Status
Active
Submission Deadline
30 days remaining
Location
Leuven, Belgium
Procedure
Negotiated procedure with prior call for competition · Supplies
Category
Pharmaceutical products.General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents.Immunosuppressive agents.
Published
Reference
ted-549131-2026
Source
Supply of Tocilizumab: 80mg/4ml, 200mg/10ml, and 400mg/20ml for intravenous use, and 162mg/0.9ml for subcutaneous use, intended for the hospital pharmacy.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 549131-2026HTML
- TED PDF — 549131-2026PDF
- TED XML — 549131-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024